Medical cannabis has been found to be a viable treatment for a wide variety of medical conditions in recent years. Studies have revealed that the plant can be effective against health issues such as chronic pain, anxiety, insomnia and depression. Furthermore, the US Food and Drug Administration has approved the use of a CBD-based drug called Epidiolex to treat seizures in pediatric epilepsy.
In Indonesia, a group of mothers is fighting to get their children access to cannabis, a plant they say could alleviate the pain caused by illnesses such as cerebral palsy. Pika Sasi Kirana was diagnosed with cerebral palsy when she was around five years old despite being a relatively healthy child for most of her young life.
Pika’s mother, Santi Warastuti, said the little girl started vomiting and fainting regularly, which prompted her parents to take her to a hospital and learn of her condition. Her health deteriorated significantly once the parents received a written diagnosis, with physicians struggling to halt the progression of the condition or find a way to give Pika a little comfort.
None of the different medications and doses that the doctors prescribed for Pika were effective, her mother said. By the time Pika required round-the-clock care and could barely do anything for herself, Warastuti was desperate for a medication that could at least make her daughter feel more comfortable.
Even though Indonesia is famous for its tough drug laws, Warastuti turned her attention to one of the most controversial drugs on the planet: medical marijuana. Warastuti, who used to work as a fashion designer, had first heard of medical cannabis when her European boss told her about the drug’s wide range of medical applications and that medical cannabis use was steadily gaining traction in Europe.
When she moved back to Yogyakarta, her hometown, Warastuti met Dwi Pratiwi, another mother interested in medical cannabis treatments for her child. Pratiwi had taken her son Musa to Australia for medical marijuana treatment and was a plaintiff in a Constitutional Court case to legalize cannabis in Indonesia. Although Musa has since died, Pratiwi said that she saw firsthand how medical cannabis helped to ease Musa’s muscular atrophy and made it easier for him to fall asleep.
The efforts of Pratiwi, Warastuti and another mother whose child has cerebral palsy to legalize cannabis have been unsuccessful so far, with the country’s Constitutional Court rejecting a motion to review Indonesia’s 2009 narcotics law. Even so, Warastuti was happy that the court ordered the government to research the medical uses of cannabis despite rejecting the mothers’ motion to legalize medical marijuana.
If only the plight of these Indonesian children could be considered and the needed reforms made, parents of children in need of medical cannabis could one day make use of advanced technologies, including the vertical gardening equipment manufactured by companies such as Advanced Container Technologies Inc. (OTC: ACTX) to cultivate their own high-quality medicinal marijuana to cut the costs of treating children.
NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CNW420.com
Do you have questions or are you interested in working with CNW420? Ask our Editor
CNW420 is part of the InvestorBrandNetwork.